NAOV

NanoVibronix Inc

NAOV, USA

NanoVibronix, Inc., through its subsidiaries, focuses on non-invasive biological response-activating devices that target biofilm prevention, pain therapy, wound healing, and at home administration without medical professional assistance. Its product portfolio includes UroShield, an ultrasound-based product that is designed to prevent bacterial colonization and biofilm in urinary catheters, increase antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use. The company also offers UroShield Ultra, which is designed to prevent bacterial colonization and biofilm formation in urinary catheters; PainShield, a patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint contractures. In addition, it provides PainShield MD, a single patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint contractures; PainShield Plus, a dual patch-based therapeutic ultrasound technology; and WoundShield, a patch-based therapeutic ultrasound device intended to facilitate tissue regeneration and wound healing. The company sells its products directly to patients, as well as through distributor agreements in the United States, Europe, Australia, Israel, New Zealand, and internationally. NanoVibronix, Inc. was incorporated in 2003 and is based in Tyler, Texas.

https://www.nanovibronix.com

Stock Price

$0.00

0%

decrease compared to yesterday.

Dividend

Frequency:

N/A

Rate:

N/A

Next Payout:

N/A
NAOV
stock
NAOV

Is NAOV in a bullish channel - Weekly Stock Analysis & Free Weekly Chart Analysis and Trade Guides bollywoodhelpline.com

Read more →
NAOV
stock
NAOV

Weekly Earnings: How NAOV stock performs after earnings - July 2025 Movers & AI Enhanced Execution Alerts Bộ Nội Vụ

Read more →

Showing 2 of 10

Finn Analysis

(Last Updated 2025-09-30)

Health Score

Price to Book Ratio (P/B)

-

Very Low

0.03

Low ≤ 1

High ≥ 3

Return on Equity (ROE)

-

Very Low

1.20 %

Low ≤ 5%

High ≥ 25%

Return on Assets (ROA)

-

Very Low

0.94 %

Low ≤ 2%

High ≥ 10%

Free Cash Flow - Revenue % (FCF)

-

Very Low

-276.73 %

Low ≤ 5%

High ≥ 15%

Debt to Equity

-

Very High

0.28

Low ≥ 1

High ≤ 0.3

Investors

* Institutions hold a combined 0.39% of the total shares of NanoVibronix Inc

1.

Morgan Stanley - Brokerage Accounts

(0.1708%)

since

2025/03/31

2.

UBS Group AG

(0.0647%)

since

2025/03/31

3.

Fidelity Extended Market Index

(0.0545%)

since

2025/07/31

4.

Citigroup Inc

(0.0314%)

since

2025/06/30

5.

Vanguard Institutional Extnd Mkt Idx Tr

(0.0237%)

since

2025/07/31

6.

Fidelity Series Total Market Index

(0.0139%)

since

2025/07/31

7.

Tower Research Capital LLC

(0.0127%)

since

2025/03/31

8.

State St US Extended Mkt Indx NL Cl C

(0.004%)

since

2025/08/31

9.

Spartan Total Market Index Pool G

(0.0037%)

since

2025/07/31

10.

Fidelity Total Market Index

(0.0022%)

since

2025/07/31

11.

SSgA U.S. Total Market Index Strategy

(0.0017%)

since

2025/03/31

12.

NT Ext Equity Mkt Idx Fd - NL

(0.0016%)

since

2025/06/30

13.

NT Ext Equity Mkt Idx Fd - DC - NL - T2

(0.0012%)

since

2025/06/30

14.

Northern Trust Extended Eq Market Idx

(0.0011%)

since

2025/06/30

15.

NT Ext Equity Mkt Idx Fd - L

(0.0011%)

since

2025/06/30

16.

NT Ext Eq Mkt Indx Fd DC Lend T3

(0.0003%)

since

2024/12/31

17.

NT Ext Eq Mkt Indx Fd DC Lending Tier 5

(0.0003%)

since

2025/06/30

18.

Bank of America Corp

(0.0001%)

since

2025/03/31

19.

SBI Securities Co Ltd

(0%)

since

2025/06/30

20.

Vanguard Group Inc

(0%)

since

2025/03/31

21.

Geode Capital Management, LLC

(0%)

since

2025/03/31

22.

Armistice Capital, LLC

(0%)

since

2025/03/31

23.

Virtu Financial LLC

(0%)

since

2025/03/31

24.

TWO SIGMA SECURITIES, LLC

(0%)

since

2025/03/31

25.

Citadel Advisors Llc

(0%)

since

2025/03/31

* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.

Earnings History

EPS ActualEPS EstimateEPS DifferenceSurprise Percent

Upcoming Earnings Release

Date

—

EPS Estimate

—

Latest Release

Date

2025-09-30

EPS Actual

-0.9086

EPS Estimate

—

EPS Difference

0

Surprise Percent

0%

Investing Fit Scorecard

(Last Updated 2025-09-30)

Deep Value
Strong Deep Value(9.5)
Defensive
Highly Defensive(7)
Dividend
Weak Dividend Profile(1.5)
Economic Moat
Wide Moat Company(6.3)
GARP
Fair GARP(4.5)
Growth
Weak Growth Prospect(3)
Momentum
No Momentum(3)
Net Net
Possible Net-Net(4)
Quality
Moderate Quality(5)
Value
Undervalued(8)

Income Statement

(Last Updated 2025-09-30)

Revenue

$ 0

Cost Of Revenue

$ 0

Gross Profit

$ 0

Operating Expenses

$ 0

Operating Income

$ 0

Interest Expense

$ 0

Pretax Income

$ 0

Net Income

$ 0

Income Tax Expense

$ 0

EBITDA

$ 0

Total Other Income Expense Net

$ 0

Earnings Per Share

0

Dividends Per Share

0

Shares Outstanding

0

Operating Margin

0%

Trend

Balance Sheet

(Last Updated 2025-09-30)

Cash

$ 0

Short Term Investments

$ 0

Receivables

$ 0

Inventories

$ 0

Total Current Assets

$ 0

Property Plant Equipment

$ 0

Total Assets

$ 0

Payables

$ 0

Short Term Debt

$ 0

Long Term Debt

$ 0

Total Liabilities

$ 0

Equity

$ 0

Trend

Cash Flow

(Last Updated 2025-09-30)

Net Income

$ 0

Depreciation

$ 0

Change In Working Capital

$ 0

Cash From Operations

$ 0

Capital Expenditures

$ 0

Cash From Investing

$ 0

Cash From Financing

$ 0

Net Change In Cash

$ 0

Trend

Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.